SDZ.SW
Healthcare Drug Manufacturers - Specialty & GenericSandoz Group AG
CHF 70.00
+1.42 +2.07% today
Price History
Not enough data
Key Stats
Market Cap
30.29B
Avg Volume
1.19M
P/E (TTM)
59.83
EPS
CHF 1.17
52W High
CHF 75.90
52W Low
CHF 47.28
Div. Yield
1.5%
Analyst Ratings
Buy3
Str Buy
4
Buy
8
Hold
1
Sell
0
Str Sell
Valuation
Forward P/E
18.51
P/B Ratio
4.18
P/S Ratio
2.59
EV/EBITDA
21.94
EV/Revenue
2.94
PEG Ratio
1.06
Margins
Gross Margin 47.8%
Operating Margin 5.2%
Net Margin 5.5%
EBITDA Margin 13.4%
Growth & Returns
Revenue Growth (YoY)
9.9%
Earnings Growth (YoY)
(71.3%)
Earnings Growth (QoQ)
(71.1%)
Return on Equity
7.2%
Return on Assets
3.0%
Liquidity & Leverage
Current Ratio
1.05
Quick Ratio
0.62
Debt / Equity
0.69
Total Cash
2.27B
Total Debt
6.20B
About
Sandoz Group AG develops, manufactures, and markets generic and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, supportive care, rare diseases, diabetes, immunology, endocrinology, neurology, osteoporosis, nephrology, hematology, and ophthalmology. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company has a strategic collaboration with Shanghai Henlius Biotech, Inc. to broaden patient access to biosimilar medicines. Sandoz Group AG was founded in 1886 and is headquartered in Basel, Switzerland.
www.sandoz.com